Viavi (VIAV) Form 144 Filed for 8,987-Share Sale on NASDAQ

Rhea-AI Filing Summary

Form 144 notice for VIAV (Viavi Solutions Inc.) reporting proposed sale of company common stock. The filing shows 8,987 shares to be sold through Morgan Stanley Smith Barney LLC on 09/25/2025 on NASDAQ with an aggregate market value of $109,369.09. The shares were acquired as performance shares from the issuer on 09/23/2025 and payment is recorded as 09/23/2025. The filer reports 223,245,915 shares outstanding for the class. The notice also discloses that the same account sold 11,873 shares on 08/29/2025 for gross proceeds of $132,693.84. The form includes the standard representation that the seller does not possess undisclosed material adverse information.

Positive

• Disclosure compliance: The filing provides required Rule 144 details including broker, sale date, class, acquisition date, and aggregate market value.
• Transparency on recent activity: The form reports both the proposed sale (8,987 shares) and a recent sale (11,873 shares with gross proceeds $132,693.84).

Negative

• None.

Insights

Securities Analyst

Routine insider sale disclosure; modest volume relative to company equity, limited market impact.

The Form 144 documents a planned sale of 8,987 common shares via Morgan Stanley Smith Barney on 09/25/2025 valued at $109,369.09, acquired two days earlier as performance shares. The filing also records a prior sale of 11,873 shares on 08/29/2025 for $132,693.84. This is a compliance-driven disclosure under Rule 144 rather than a corporate-action announcement. Because the filing contains only the proposed sale quantities, acquisition dates, and gross proceeds for the prior sale, there is no additional financial data to suggest material impact on the company’s operations or capital structure.

Corporate Governance Expert

Disclosure meets Rule 144 requirements; provides transparency on insider share movements without revealing intent.

The notice identifies the broker, sale date, class, and acquisition details consistent with Rule 144 reporting practices. The filer affirms absence of undisclosed material adverse information. The record of a recent prior sale and the proximity of acquisition-to-sale dates are factual disclosures only. The document does not include any governance actions, policy changes, or statements that would alter shareholder rights or company governance frameworks.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	8987	109369.09	223245915	09/25/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/23/2025	Performance Shares	ISSUER			8987	09/23/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
LUKE SCRIVANICH 1445 South Spectrum Blvd Suite 102 Chandler AZ 85286	Common	08/29/2025	11873	132693.84

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does VIAV's Form 144 filed for 09/25/2025 disclose?

The form discloses a proposed sale of 8,987 common shares through Morgan Stanley Smith Barney on 09/25/2025 with an aggregate market value of $109,369.09.

How and when were the 8,987 shares acquired for sale on 09/25/2025?

The shares were acquired as performance shares from the issuer on 09/23/2025, with payment recorded on 09/23/2025.

Did the filer sell any VIAV shares recently prior to this Form 144?

Yes, the filing reports a prior sale of 11,873 shares on 08/29/2025 that generated gross proceeds of $132,693.84.

On which exchange will the proposed sale occur?

The proposed sale is listed to occur on NASDAQ via Morgan Stanley Smith Barney LLC.

How many VIAV shares outstanding does the filing report?

The filing reports 223,245,915 shares outstanding for the class.

Does the filer assert possession of any undisclosed material information?

No; the notice includes the required representation that the person does not know of any materially adverse undisclosed information regarding the issuer.